Gerald E. Harders

582 citations

18 papers · 449 indexed · h-index 10

Co-authors: John C. Burnett S. Jeson Sangaralingham Tomoko Ichiki Brenda K. Huntley Fernando L. Martín Paul M. McKie Horng H. Chen Diego Bellavia
Topics: Heart Failure Treatment and Management (8 papers)Renin-Angiotensin System Studies (4 papers)Hormonal Regulation and Hypertension (4 papers)
Cited by: Cardiology and Cardiovascular Medicine Nephrology Endocrinology, Diabetes and Metabolism
Journals: Circulation Journal of the American College of Cardiology PLoS ONE
Partner nations: United States India Italy

In The Last Decade

Gerald E. Harders

17 papers receiving 440 citations

Peers

Countries citing papers authored by Gerald E. Harders

Since Specialization

Citations

This map shows the geographic impact of Gerald E. Harders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald E. Harders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald E. Harders more than expected).

Fields of papers citing papers by Gerald E. Harders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald E. Harders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald E. Harders. The network helps show where Gerald E. Harders may publish in the future.

Co-authorship network of co-authors of Gerald E. Harders

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald E. Harders. A scholar is included among the top collaborators of Gerald E. Harders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald E. Harders. Gerald E. Harders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Long-term blood pressure lowering and cGMP-activating actions of the novel ANP analog MANP 2020 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Yang Chen,(unknown),Seethalakshmi Iyer,Gerald E. Harders,Shuchong Pan,S. Jeson Sangaralingham,Horng H. Chen,Margaret M. Redfield,John C. Burnett	15
2	C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts 2019 ·Journal of Molecular and Cellular Cardiology ·Chen Yang,Ye Zheng,Seethalakshmi Iyer,Gerald E. Harders,Shuchong Pan,Horng H. Chen,Tomoko Ichiki,John C. Burnett,S. Jeson Sangaralingham	22
3	THE NOVEL GC-A/CGMP ACTIVATING DESIGNER M-ATRIAL NATRIURETIC PEPTIDE POTENTLY REDUCES BLOOD PRESSURE IN A GENETIC MODEL OF HYPERTENSION AND POTENTIATES THE ACTIONS OF FUROSEMIDE 2019 ·Journal of the American College of Cardiology ·(unknown),Seethalakshmi Iyer,Yang Chen,Gerald E. Harders,(unknown),Horng Chen,John C. Burnett	1
4	Design, Synthesis, and Actions of an Innovative Bispecific Designer Peptide 2019 ·Hypertension ·Laura M.G. Meems,(unknown),Shuchong Pan,Gail J. Harty,Yang Chen,Ye Zheng,Gerald E. Harders,Tomoko Ichiki,Denise M. Heublein,Seethalakshmi Iyer,S. Jeson Sangaralingham,Daniel McCormick,John C. Burnett	19
5	CRRL269: a novel designer and renal-enhancing pGC-A peptide activator 2017 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Chen Yang,Gail J. Harty,Brenda K. Huntley,Seethalakshmi Iyer,Denise M. Heublein,Gerald E. Harders,Laura M.G. Meems,Shuchong Pan,S. Jeson Sangaralingham,Tomoko Ichiki,John C. Burnett	17
6	Abstract 12236: A Novel Particulate Guanylyl Cyclase B Agonist With Therapeutic Potential Targeting Fibrosis via cGMP Generation for Cardiorenal Disease 2015 ·Circulation ·S. Jeson Sangaralingham,Brenda K. Huntley,Tomoko Ichiki,Gerald E. Harders,John C. Burnett	1
7	CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart 2012 ·PLoS ONE ·Fernando L. Martín,S. Jeson Sangaralingham,Brenda K. Huntley,Paul M. McKie,Tomoko Ichiki,Horng H. Chen,Josef Kořínek,Gerald E. Harders,John C. Burnett	48
8	575 Cenderitide: A Novel Designer Natriuretic Peptide Therapeutic Strategy for the Prevention of Adverse Cardiac Fibrosis and Diastolic Dysfunction Induced by Mild Renal Insufficiency 2012 ·Canadian Journal of Cardiology ·S. Jeson Sangaralingham,Fernando L. Martín,(unknown),Paul M. McKie,Tomoko Ichiki,Gerald E. Harders,(unknown),J.C. Burnett	1
9	Cardiac Micro–Computed Tomography Imaging of the Aging Coronary Vasculature 2012 ·Circulation Cardiovascular Imaging ·S. Jeson Sangaralingham,Erik L. Ritman,Paul M. McKie,Tomoko Ichiki,Amir Lerman,Christopher G. Scott,Fernando L. Martín,Gerald E. Harders,Diego Bellavia,John C. Burnett	24
10	Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis 2012 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Tomoko Ichiki,Guido Boerrigter,Brenda K. Huntley,S. Jeson Sangaralingham,Paul M. McKie,Gail J. Harty,Gerald E. Harders,John C. Burnett	53
11	MANP: A Novel Designer Natriuretic Peptide for Cardiometabolic Disease 2012 ·Journal of Cardiac Failure ·Valentina Cannone,Brenda K. Huntley,Denise M. Heublein,Sharon M. Sandberg,Gerald E. Harders,(unknown),Fernando L. Martín,John C. Burnett	1
12	Long-Term Cardiac pro-B-Type Natriuretic Peptide Gene Delivery Prevents the Development of Hypertensive Heart Disease in Spontaneously Hypertensive Rats 2011 ·Circulation ·Alessandro Cataliotti,Jason M. Tonne,Diego Bellavia,Fernando L. Martín,Elise A. Oehler,Gerald E. Harders,Jarryd M. Campbell,(unknown),Stephen J. Russell,Lorenzo Malatino,John C. Burnett,Yasuhiro Ikeda	69
13	Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection 2011 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Fernando L. Martín,Paul M. McKie,Alessandro Cataliotti,S. Jeson Sangaralingham,Josef Kořínek,Brenda K. Huntley,Elise A. Oehler,Gerald E. Harders,Tomoko Ichiki,Sarah Mangiafico,Karl A. Nath,Margaret M. Redfield,Horng H. Chen,John C. Burnett	73
14	Cenderitide, a novel dual GC-A and GC-B receptor activator, is a potent chronic cardiorenal fibroinhibiting peptide which suppresses aldosterone and reduces proteinuria in models of ardiorenal fibrosis 2011 ·BMC Pharmacology ·Fernando L. Martín,Paul M. McKie,(unknown),Tomoko Ichiki,Gerald E. Harders,Horng H. Chen,John C. Burnett	1
15	The Aging Heart, Myocardial Fibrosis, and its Relationship to Circulating C-Type Natriuretic Peptide 2010 ·Hypertension ·S. Jeson Sangaralingham,Brenda K. Huntley,Fernando L. Martín,Paul M. McKie,Diego Bellavia,Tomoko Ichiki,Gerald E. Harders,Horng H. Chen,John C. Burnett	94
16	Prevention of Cardiorenal Fibrosis and Suppression of Proteinuria and Aldosterone Activation Following Experimental Myocardial Infarction with the Novel Natriuretic Peptide CD-NP 2009 ·Journal of Cardiac Failure ·Fernando L. Martín,S. Jeson Sangaralingham,Paul M. McKie,Brenda K. Huntley,Gerald E. Harders,Horng H. Chen,John C. Burnett	6
17	Abstract 383: Heart-Kidney: Myocardial Infarction Mediates Renal Fibrosis and Activates Renal Molecular Remodeling in the Absence of Heart Failure 2007 ·Circulation ·Fernando L. Martín,Brenda K. Huntley,Gerald E. Harders,Sharon M. Sandberg,Horng H. Chen,John C. Burnett	3
18	Cardiac-specific gain-of-function mutation in the natriuretic peptide a receptor is associated with improved diastolic function in presence and absence of pressure overload hypertrophy 2003 ·Journal of the American College of Cardiology ·(unknown),Maria L. Valencik,John A. McDonald,Gerald E. Harders,Margaret M. Redfield	1

About Gerald E. Harders

Gerald E. Harders is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 449 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (8 papers), Renin-Angiotensin System Studies (4 papers) and Hormonal Regulation and Hypertension (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (328 citations), Nephrology (41 citations) and Endocrinology, Diabetes and Metabolism (49 citations). Gerald E. Harders has collaborated with scholars based in United States, India and Italy. Frequent co-authors include John C. Burnett, S. Jeson Sangaralingham, Tomoko Ichiki, Brenda K. Huntley, Fernando L. Martín, Paul M. McKie, Horng H. Chen, Diego Bellavia, Alessandro Cataliotti and Elise A. Oehler. Their work appears in journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact